Home LiteratureArticle Details
PMID: 1727475 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein.

Journal of virology ·Vol. 66 ·No. 1 ·1992-01-00 ·Pages 132-8

Dimitrov DS, Hillman K, Manischewitz J, Blumenthal R, Golding H

Abstract

The high-affinity interaction between the envelope glycoprotein (gp120-gp41) of the human immunodeficiency virus type 1 and its receptor, CD4, is important for viral entry into cells and therapeutical approaches based on the soluble form of CD4 (sCD4). Using flow cytometry, we studied the kinetics of binding of sCD4 to gp120-gp41 expressed on the cell surface. sCD4 binding was dependent on sCD4 concentration and temperature and exhibited bimolecular reaction kinetics. Binding was very slow at low sCD4 concentrations (below 0.2 micrograms/ml) and low temperatures (below 13 degrees C) but increased sharply with increasing temperature. The rate constant for association at 37 degrees C (1.5 x 10(5) M-1 s-1) was 14-fold higher than at 4 degrees C, but the affinity of sCD4 to membrane-bound gp120-gp41 was not significantly affected. The activation energy at higher temperatures (28 to 37 degrees C) was less than at lower temperatures (4 to 13 degrees C). After long periods of incubation, we observed a decrease of surface-bound sCD4 and gp120, even at low temperatures, which was attributed to sCD4-induced shedding of gp120. The rate of gp120 shedding was much lower than the rate of sCD4 binding and was dependent on sCD4 concentration and temperature. The finding that sCD4 binding is slow, especially at low sCD4 concentrations, can be of critical importance for efficient blocking of viral infection by sCD4 and should be considered when designing new protocols in the therapy of AIDS patients.

MeSH Terms
CD4 Antigens/metabolism Cell Line Flow Cytometry HIV Envelope Protein gp120/metabolism HIV Envelope Protein gp41/metabolism HIV-1/metabolism Humans Kinetics Membrane Proteins/metabolism Solubility T-Lymphocytes/metabolism,microbiology Temperature
Chemicals
CD4 Antigens HIV Envelope Protein gp120 HIV Envelope Protein gp41 Membrane Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Dimitrov D S
Section on Membrane Structure and Function, National Cancer Institute, Bethesda, Maryland 20892.
Hillman K
Manischewitz J
Blumenthal R
Golding H
References (30)
30 references, click to expand
  1. Soluble CD4 molecules neutralize human immunodeficiency virus type 1.
    Nature. 1988 Jan 7;331(6151):84-6 PMID: 2829024
  2. Quantitative measurement of fusion between human immunodeficiency virus and cultured cells using membrane fluorescence dequenching.
    FEBS Lett. 1988 Oct 24;239(1):88-92 PMID: 2846352
  3. HIV infection is blocked in vitro by recombinant soluble CD4.
    Nature. 1988 Jan 7;331(6151):76-8 PMID: 2829022
  4. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
    Nature. 1986 Jul 31-Aug 6;322(6078):470-4 PMID: 3016552
  5. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion.
    Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8082-6 PMID: 1896455
  6. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.
    Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2189-93 PMID: 2006155
  7. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.
    Nature. 1986 Oct 23-29;323(6090):725-8 PMID: 3095663
  8. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule.
    Science. 1986 Jan 24;231(4736):382-5 PMID: 3001934
  9. Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4.
    J Virol. 1991 Mar;65(3):1133-40 PMID: 1995942
  10. pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane.
    Cell. 1987 Jun 5;49(5):659-68 PMID: 3107838
  11. Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4.
    J Virol. 1989 Oct;63(10):4370-5 PMID: 2550671
  12. Designing CD4 immunoadhesins for AIDS therapy.
    Nature. 1989 Feb 9;337(6207):525-31 PMID: 2536900
  13. Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by recombinant soluble CD4 and 3'-azido-3'-deoxythymidine.
    J Infect Dis. 1989 May;159(5):837-44 PMID: 2785146
  14. Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism.
    EMBO J. 1988 Feb;7(2):513-8 PMID: 3259178
  15. A soluble form of CD4 (T4) protein inhibits AIDS virus infection.
    Nature. 1988 Jan 7;331(6151):82-4 PMID: 3257544
  16. Glycosylation of CD4. Tunicamycin inhibits surface expression.
    J Biol Chem. 1988 Jul 5;263(19):9502-7 PMID: 3259951
  17. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):767-8 PMID: 6083454
  18. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):763-7 PMID: 6096719
  19. Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen.
    Science. 1987 Dec 18;238(4834):1704-7 PMID: 3500514
  20. Cytofluorometric quantification of cell-surface antigens by indirect immunofluorescence using monoclonal antibodies.
    J Immunol Methods. 1985 Dec 17;85(1):65-74 PMID: 3908562
  21. A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site.
    Cell. 1990 Mar 9;60(5):747-54 PMID: 2107024
  22. Chemically induced CD4 mutants of a human T cell line. Evidence for dissociation between binding of HIV I envelope and susceptibility to HIV I infection and syncytia formation.
    J Immunol. 1990 Mar 15;144(6):2131-9 PMID: 1690235
  23. HIV: early virus-cell interactions.
    J Acquir Immune Defic Syndr. 1990;3(10):965-74 PMID: 2398460
  24. HIV requires multiple gp120 molecules for CD4-mediated infection.
    Nature. 1990 Jul 19;346(6281):277-9 PMID: 2374593
  25. The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study.
    Ann Intern Med. 1990 Feb 15;112(4):254-61 PMID: 2297204
  26. Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial.
    Ann Intern Med. 1990 Feb 15;112(4):247-53 PMID: 2297203
  27. Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses.
    J Virol. 1991 Jan;65(1):31-41 PMID: 1985202
  28. Dissociation of gp120 from HIV-1 virions induced by soluble CD4.
    Science. 1990 Nov 23;250(4984):1139-42 PMID: 2251501
  29. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.
    Cell. 1986 Nov 7;47(3):333-48 PMID: 3094962
  30. A soluble CD4 protein selectively inhibits HIV replication and syncytium formation.
    Nature. 1988 Jan 7;331(6151):78-81 PMID: 2829023
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1992-01-00
Pages
132-8
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC238268
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]